Skip to main content
NCBI home page
Biochemical Journal logoLink to Biochemical Journal
. 1999 Feb 1;337(Pt 3):567–574.

Cloning and characterization of a simian UDP-glucuronosyltransferase enzyme UGT2B20, a novel C19 steroid-conjugating protein.

O Barbier 1, A Bélanger 1, D W Hum 1
PMCID: PMC1220011  PMID: 9895303

Abstract

Steroid glucuronidation by UDP-glucuronosyltransferase (UGT) enzymes is a mechanism leading to catabolism and elimination of steroid hormones. To establish an animal model to investigate the conjugation of steroids by UGT enzymes, previous results revealed that simian and human are unique in having high levels of circulating androsterone glucuronide and androstane-3alpha, 17beta-diol (3d-Diol) glucuronide. A cDNA, UGT2B20, was isolated from cynomolgus monkey liver and prostate libraries. The cDNA was 2075 bp in length and contained an open reading frame of 1590 bp, encoding a protein of 530 amino acid residues. The UGT2B20 clone was transfected and stably expressed in the human embryo kidney HK293 cell line, and the transferase activity of UGT2B20 was tested with 73 compounds. This enzyme was shown to be active with androgens, such as testosterone, dihydrotestosterone (DHT) and 3alpha-Diol, and on catecholoestrogens including 1,3,5,10-oestratriene-3, 4-diol-17-one. Kinetic analysis performed with intact cells yielded apparent Km values of 1.1, 2.3 and 4.6 microM for 3alpha-Diol, DHT and testosterone respectively. Reverse transcriptase-PCR analysis demonstrated that UGT2B20 transcript is expressed in several tissues including the liver, prostate, kidney, epididymis and adrenal of the cynomolgus monkey. Amino acid sequence alignment shows that the UGT2B20 protein is 92% identical with UGT2B15. Both enzymes have similar apparent Km values for DHT and 3alpha-Diol, and demonstrate similar transcript tissue distribution. The characterization of simian UGT2B20 as a structural and functional homologue of human UGT2B15 further demonstrates the similarities of steroid glucuronidation in these two species, and indicates the relevance of using the monkey as an animal model to study and understand steroid glucuronidation in extrahepatic-steroid target tissues.

Full Text

The Full Text of this article is available as a PDF (205.1 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Beaulieu M., Lévesque E., Barbier O., Turgeon D., Bélanger G., Hum D. W., Bélanger A. Isolation and characterization of a simian UDP-glucuronosyltransferase UGT2B18 active on 3-hydroxyandrogens. J Mol Biol. 1998 Feb 6;275(5):785–794. doi: 10.1006/jmbi.1997.1486. [DOI] [PubMed] [Google Scholar]
  2. Beaulieu M., Lévesque E., Hum D. W., Bélanger A. Isolation and characterization of a novel cDNA encoding a human UDP-glucuronosyltransferase active on C19 steroids. J Biol Chem. 1996 Sep 13;271(37):22855–22862. doi: 10.1074/jbc.271.37.22855. [DOI] [PubMed] [Google Scholar]
  3. Beaulieu M., Lévesque E., Tchernof A., Beatty B. G., Bélanger A., Hum D. W. Chromosomal localization, structure, and regulation of the UGT2B17 gene, encoding a C19 steroid metabolizing enzyme. DNA Cell Biol. 1997 Oct;16(10):1143–1154. doi: 10.1089/dna.1997.16.1143. [DOI] [PubMed] [Google Scholar]
  4. Burchell B., Nebert D. W., Nelson D. R., Bock K. W., Iyanagi T., Jansen P. L., Lancet D., Mulder G. J., Chowdhury J. R., Siest G. The UDP glucuronosyltransferase gene superfamily: suggested nomenclature based on evolutionary divergence. DNA Cell Biol. 1991 Sep;10(7):487–494. doi: 10.1089/dna.1991.10.487. [DOI] [PubMed] [Google Scholar]
  5. Bélanger A., Brochu M., Lacoste D., Noël C., Labrie F., Dupont A., Cusan L., Caron S., Couture J. Steroid glucuronides: human circulatory levels and formation by LNCaP cells. J Steroid Biochem Mol Biol. 1991;40(4-6):593–598. doi: 10.1016/0960-0760(91)90281-9. [DOI] [PubMed] [Google Scholar]
  6. Bélanger A., Hum D. W., Beaulieu M., Lévesque E., Guillemette C., Tchernof A., Bélanger G., Turgeon D., Dubois S. Characterization and regulation of UDP-glucuronosyltransferases in steroid target tissues. J Steroid Biochem Mol Biol. 1998 Apr;65(1-6):301–310. doi: 10.1016/s0960-0760(97)00183-0. [DOI] [PubMed] [Google Scholar]
  7. Bélanger G., Beaulieu M., Lévesque E., Hum D. W., Bélanger A. Expression and characterization of a novel UDP-glucuronosyltransferase, UGT2B9, from cynomolgus monkey. DNA Cell Biol. 1997 Oct;16(10):1195–1205. doi: 10.1089/dna.1997.16.1195. [DOI] [PubMed] [Google Scholar]
  8. Fiszer-Szafarz B., Szafarz D., Guevara de Murillo A. A general, fast, and sensitive micromethod for DNA determination application to rat and mouse liver, rat hepatoma, human leukocytes, chicken fibroblasts, and yeast cells. Anal Biochem. 1981 Jan 1;110(1):165–170. doi: 10.1016/0003-2697(81)90130-5. [DOI] [PubMed] [Google Scholar]
  9. Green M. D., Oturu E. M., Tephly T. R. Stable expression of a human liver UDP-glucuronosyltransferase (UGT2B15) with activity toward steroid and xenobiotic substrates. Drug Metab Dispos. 1994 Sep-Oct;22(5):799–805. [PubMed] [Google Scholar]
  10. Guillemette C., Hum D. W., Bélanger A. Levels of plasma C19 steroids and 5 alpha-reduced C19 steroid glucuronides in primates, rodents, and domestic animals. Am J Physiol. 1996 Aug;271(2 Pt 1):E348–E353. doi: 10.1152/ajpendo.1996.271.2.E348. [DOI] [PubMed] [Google Scholar]
  11. Guillemette C., Hum D. W., Bélanger A. Specificity of glucuronosyltransferase activity in the human cancer cell line LNCaP, evidence for the presence of at least two glucuronosyltransferase enzymes. J Steroid Biochem Mol Biol. 1995 Dec;55(3-4):355–362. doi: 10.1016/0960-0760(95)00183-2. [DOI] [PubMed] [Google Scholar]
  12. Guillemette C., Lévesque E., Beaulieu M., Turgeon D., Hum D. W., Bélanger A. Differential regulation of two uridine diphospho-glucuronosyltransferases, UGT2B15 and UGT2B17, in human prostate LNCaP cells. Endocrinology. 1997 Jul;138(7):2998–3005. doi: 10.1210/endo.138.7.5226. [DOI] [PubMed] [Google Scholar]
  13. Labrie F., Bélanger A., Cusan L., Candas B. Physiological changes in dehydroepiandrosterone are not reflected by serum levels of active androgens and estrogens but of their metabolites: intracrinology. J Clin Endocrinol Metab. 1997 Aug;82(8):2403–2409. doi: 10.1210/jcem.82.8.4161. [DOI] [PubMed] [Google Scholar]
  14. Labrie F. Intracrinology. Mol Cell Endocrinol. 1991 Jul;78(3):C113–C118. doi: 10.1016/0303-7207(91)90116-a. [DOI] [PubMed] [Google Scholar]
  15. Lévesque E., Beaulieu M., Green M. D., Tephly T. R., Bélanger A., Hum D. W. Isolation and characterization of UGT2B15(Y85): a UDP-glucuronosyltransferase encoded by a polymorphic gene. Pharmacogenetics. 1997 Aug;7(4):317–325. doi: 10.1097/00008571-199708000-00007. [DOI] [PubMed] [Google Scholar]
  16. Lévesque E., Beaulieu M., Guillemette C., Hum D. W., Bélanger A. Effect of interleukins on UGT2B15 and UGT2B17 steroid uridine diphosphate-glucuronosyltransferase expression and activity in the LNCaP cell line. Endocrinology. 1998 May;139(5):2375–2381. doi: 10.1210/endo.139.5.6001. [DOI] [PubMed] [Google Scholar]
  17. Mackenzie P. I., Mojarrabi B., Meech R., Hansen A. Steroid UDP glucuronosyltransferases: characterization and regulation. J Endocrinol. 1996 Sep;150 (Suppl):S79–S86. [PubMed] [Google Scholar]
  18. Mackenzie P. I., Owens I. S., Burchell B., Bock K. W., Bairoch A., Bélanger A., Fournel-Gigleux S., Green M., Hum D. W., Iyanagi T. The UDP glycosyltransferase gene superfamily: recommended nomenclature update based on evolutionary divergence. Pharmacogenetics. 1997 Aug;7(4):255–269. doi: 10.1097/00008571-199708000-00001. [DOI] [PubMed] [Google Scholar]
  19. Mackenzie P. I. The effect of N-linked glycosylation on the substrate preferences of UDP glucuronosyltransferases. Biochem Biophys Res Commun. 1990 Feb 14;166(3):1293–1299. doi: 10.1016/0006-291x(90)91006-e. [DOI] [PubMed] [Google Scholar]
  20. Miyazaki Y., Matsufuji S., Murakami Y., Hayashi S. Single amino-acid replacement is responsible for the stabilization of ornithine decarboxylase in HMOA cells. Eur J Biochem. 1993 Jun 15;214(3):837–844. doi: 10.1111/j.1432-1033.1993.tb17987.x. [DOI] [PubMed] [Google Scholar]
  21. Rhéaume E., Sirois I., Labrie F., Simard J. Codon 367 polymorphism of the human type I 3 beta-hydroxysteroid dehydrogenase/isomerase gene (HS5DB3). Nucleic Acids Res. 1991 Nov 11;19(21):6060–6060. doi: 10.1093/nar/19.21.6060. [DOI] [PMC free article] [PubMed] [Google Scholar]
  22. Sharer J. E., Shipley L. A., Vandenbranden M. R., Binkley S. N., Wrighton S. A. Comparisons of phase I and phase II in vitro hepatic enzyme activities of human, dog, rhesus monkey, and cynomolgus monkey. Drug Metab Dispos. 1995 Nov;23(11):1231–1241. [PubMed] [Google Scholar]
  23. Tephly T., Green M., Puig J., Irshaid Y. Endogenous substrates for UDP-glucuronosyltransferases. Xenobiotica. 1988 Nov;18(11):1201–1210. doi: 10.3109/00498258809042244. [DOI] [PubMed] [Google Scholar]

Articles from Biochemical Journal are provided here courtesy of The Biochemical Society

RESOURCES